Related Concepts
Related Feeds
AML: Role of LSD1 by CRISPR (Keystone)
Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.
Acute Myeloid Leukemia
Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.
B-Cell Leukemia (Keystone)
B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.
Related Papers
Seminars in Hematology
Daniela Cilloni, Giuseppe Saglio
Haematologica
Eva BarragánMiguel Angel Sanz
Acta Haematologica
Daniela Cilloni, Giuseppe Saglio
Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme
T Akiyama
Methods in Molecular Medicine
H Sugiyama